Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia

Ann Hematol. 2024 May 11. doi: 10.1007/s00277-024-05789-7. Online ahead of print.

Markus Tölle¹, Nicola Gökbuget^{2

3}, Stefan Habringer^{4

5}, Ulrich Keller^{4

5}, Stefan Schwartz^{6

7}

¹ Department of Nephrology and Medical Intensive Care (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany.
² Medizinische Klinik II, Universitätsklinikum der Johann-Wolfgang-Goethe Universität, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany.
³ German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, a partnership between DKFZ and Johann-Wolfgang-Goethe Universität, 60596, Frankfurt/Main, Germany.
⁴ Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany.
⁵ German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, 12203, Berlin, Germany.
⁶ Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany. stefan.schwartz@charite.de.
⁷ German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, 12203, Berlin, Germany. stefan.schwartz@charite.de.

No abstract available